Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
2017
Y 4.G 74/7:115-33
Linked e-resources
Linked Resource
Details
Title
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
Corporate Author
Published
Washington : U.S. Government Publishing Office, 2017.
Language
English
Description
iii, 54 pages ; 24 cm
Call Number
Y 4.G 74/7:115-33
GPO Item No.
1016-B (MF)
Note
"Serial no. 115-33."
Shipping list no.: 2018-0099-M.
Shipping list no.: 2018-0099-M.
Bibliography, etc. Note
Includes bibliographical references.
Reproduction
Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2018] 1 microfiche : negative.
Linked Resources
Record Appears in